A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise

Overview[ - collapse ][ - ]

Purpose The purpose of this study is to assess the effectiveness of the co-administration of canagliflozin and metformin extended release (XR) compared with canagliflozin alone, and metformin XR alone in patients with type 2 diabetes mellitus with inadequate control despite treatment with diet and exercise. The safety and tolerability of canagliflozin will also be assessed.
ConditionDiabetes Mellitus, Type 2
InterventionDrug: Canagliflozin 100 mg
Drug: Canagliflozin 300 mg
Drug: Metformin XR
PhasePhase 3
SponsorJanssen Research & Development, LLC
Responsible PartyJanssen Research & Development, LLC
ClinicalTrials.gov IdentifierNCT01809327
First ReceivedMarch 8, 2013
Last UpdatedApril 11, 2014
Last verifiedApril 2014

Tracking Information[ + expand ][ + ]

First Received DateMarch 8, 2013
Last Updated DateApril 11, 2014
Start DateJune 2013
Estimated Primary Completion DateDecember 2014
Current Primary Outcome MeasuresChange in glycated hemoglobin (HbA1c) from baseline to Week 26 [Time Frame: Day 1 (Baseline) up to Week 26] [Designated as safety issue: No]The change in HbA1c will be compared between the different treatment groups.
Current Secondary Outcome Measures
  • Percent change in body weight from baseline to Week 26 [Time Frame: Day 1 (Baseline) up to Week 26] [Designated as safety issue: No]The percent change in body weight will be compared between the different treatment groups.
  • Percentage of participants with glycated hemoglobin (HbAIc) less than 7 percent at Week 26 [Time Frame: Week 26] [Designated as safety issue: No]The percentage of participants with HbAIc less than 7 percent will be compared between the different treatment groups.
  • Change in systolic blood pressure from baseline to Week 26 [Time Frame: Day 1 (Baseline) up to Week 26] [Designated as safety issue: No]The change in systolic blood pressure will be compared between the different treatment groups.
  • Change in high-density lipoprotein cholesterol (HDL-C) from baseline to Week 26 [Time Frame: Day 1 (Baseline) up to Week 26] [Designated as safety issue: No]The change in HDL-C will be compared between the different treatment groups.
  • Change in triglycerides from baseline to Week 26 [Time Frame: Day 1 (Baseline) up to Week 26] [Designated as safety issue: No]The change in triglycerides will be compared between the different treatment groups.
  • Number of participants with adverse events [Time Frame: Up to 30 weeks] [Designated as safety issue: Yes]Number of participants with adverse events will be used as a measure of safety and tolerability.

Descriptive Information[ + expand ][ + ]

Brief TitleA Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise
Official TitleA Randomized, Double-Blind, 5-Arm, Parallel-Group, 26-Week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in Combination With Metformin as Initial Combination Therapy in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise
Brief Summary
The purpose of this study is to assess the effectiveness of the co-administration of
canagliflozin and metformin extended release (XR) compared with canagliflozin alone, and
metformin XR alone in patients with type 2 diabetes mellitus with inadequate control despite
treatment with diet and exercise. The safety and tolerability of canagliflozin will also be
assessed.
Detailed Description
This study will be a randomized (the study medication is assigned by chance), double-blind
(neither physician nor participant knows the identity of the assigned treatment),
active-controlled (one of the treatments is an established effective treatment for type 2
diabetes mellitus), parallel-group (each group of participants will be treated at the same
time), 5-arm (groups), multicenter study. Approximately 1,200 participants will be randomly
assigned to the 5 treatment arms in a 1:1:1:1:1 ratio for 26 weeks.
Study TypeInterventional
Study PhasePhase 3
Study DesignAllocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
ConditionDiabetes Mellitus, Type 2
InterventionDrug: Canagliflozin 100 mg
One 100 mg capsule taken orally (by mouth) once daily either before the morning meal (for the Canagliflozin 100 mg arm) or with the evening meal (for the Canagliflozin 100 mg + Metformin XR arm).
Drug: Canagliflozin 300 mg
One 300 mg capsule taken orally (by mouth) once daily either before the morning meal (for the Canagliflozin 300 mg arm) or with the evening meal (for the Canagliflozin 300 mg + Metformin XR arm).
Drug: Metformin XR
One 500 mg tablet (Day 1 up to week 1); two 500 mg tablets (Week 1 up to Week 3); three 500 mg tablets (Week 3 to Week 6); four 500 mg tablets (Week 6 to Week 9). Tablets will be administered with the evening meal.
Study Arm (s)
  • Experimental: Canagliflozin 100 mg
    Participants will receive one 100 mg canagliflozin capsule before the morning meal and one matching placebo capsule with the evening meal plus placebo tablets with the evening meal (to match the metformin XR tablets administered in other treatment arms) for 26 weeks.
  • Experimental: Canagliflozin 300 mg
    Participants will receive one 300 mg canagliflozin capsule before the morning meal and one matching placebo capsule with the evening meal plus placebo tablets with the evening meal (to match the metformin XR tablets administered in other treatment arms) for 26 weeks.
  • Experimental: Metformin XR
    Participants will receive metformin XR tablets (in doses titrated over 9 weeks) once daily with the evening meal, plus one placebo capsule before the morning meal and one placebo capsule with the evening meal (to match the canagliflozin capsules administered in other treatment arms) for 26 weeks.
  • Experimental: Canagliflozin 100 mg + Metformin XR
    Participants will receive one 100 mg canagliflozin capsule with the evening meal and one matching placebo capsule before the morning meal plus metformin XR tablets (in doses titrated over 9 weeks) once daily with the evening meal for 26 weeks.
  • Experimental: Canagliflozin 300 mg + Metformin XR
    Participants will receive one 300 mg canagliflozin capsule with the evening meal and one matching placebo capsule before the morning meal plus metformin XR tablets (in doses titrated over 9 weeks) once daily with the evening meal for 26 weeks.

Recruitment Information[ + expand ][ + ]

Recruitment StatusRecruiting
Estimated Enrollment1200
Estimated Completion DateDecember 2014
Estimated Primary Completion DateMay 2014
Eligibility Criteria
Inclusion Criteria:

- Must have type 2 diabetes mellitus with inadequate glycemic control on diet and
exercise

- Not on antihyperglycemic agent therapy (at least 12 weeks before screening) and have
a screening visit fingerstick glycated hemoglobin (HbA1c) of more than or equal to 7
percent and less than or equal to 12.5 percent

- Have a screening visit HbA1c of more than or equal to 7.5 percent and less than or
equal to 12 percent as determined by the central laboratory

- Must have a fasting plasma glucose of less than or equal to 300 mg/dL (16.7 mmol/L)
prior to randomization

- Must have a fasting fingerstick glucose of greater than 120 mg/dL (6.7 mmol/L)
performed at home or at the study center prior to randomization

Exclusion Criteria:

- History of diabetic ketoacidosis, type 1 diabetes mellitus (T1DM), pancreas or
beta-cell transplantation, or diabetes secondary to pancreatitis or pancreatectomy

- Fasting C-peptide less than 0.70 ng/mL (0.23 nmol/L) in participants for whom the
investigator cannot reasonably exclude T1DM based upon clinical evaluation

- Repeated (2 or more over a 1 week period) fasting self-monitored blood glucose
measurements more than 300 mg/dL (16.7 mmol/L) prior to randomization, despite
reinforcement of diet and exercise counseling

- History of hereditary glucose-galactose malabsorption or primary renal glucosuria

- Has history of, or currently active, illness considered to be clinically significant
by the Investigator or any other illness that the Investigator considers should
exclude the patient from the study or that could interfere with the interpretation of
the study results
GenderBoth
Ages18 Years
Accepts Healthy VolunteersNo
ContactsContact: Use link at the bottom of the page to see if you qualify for an enrolling site (see list). If you still have questions:
JNJ.CT@sylogent.com
Location CountriesUnited States, Argentina, Brazil, Czech Republic, Hungary, Korea, Republic of, Mexico, Romania, Russian Federation, Slovakia, South Africa, Turkey, Ukraine

Administrative Information[ + expand ][ + ]

NCT Number NCT01809327
Other Study ID NumbersCR100034
Has Data Monitoring CommitteeYes
Information Provided ByJanssen Research & Development, LLC
Study SponsorJanssen Research & Development, LLC
CollaboratorsNot Provided
Investigators Study Director: Janssen Research & Development, LLC Clinical Trial Janssen Research & Development, LLC
Verification DateApril 2014

Locations[ + expand ][ + ]

United States, Alabama
Anniston, Alabama, United States
Withdrawn
United States, Alabama
Birmingham, Alabama, United States
Recruiting
United States, Arizona
Mesa, Arizona, United States
Withdrawn
United States, Arizona
Phoenix, Arizona, United States
Recruiting
United States, Arizona
Phoenix, Arizona, United States
Completed
United States, California
Concord, California, United States
Withdrawn
United States, California
Encinitas, California, United States
Recruiting
United States, California
Greenbrae, California, United States
Withdrawn
United States, California
Newport Beach, California, United States
Completed
United States, California
Northridge, California, United States
Recruiting
United States, California
Norwalk, California, United States
Recruiting
United States, California
Rancho Cucamonga, California, United States
Recruiting
United States, California
Spring Valley, California, United States
Withdrawn
United States, California
Walnut Creek, California, United States
Recruiting
United States, Colorado
Denver, Colorado, United States
Recruiting
United States, Colorado
Northglenn, Colorado, United States
Completed
United States, Connecticut
Waterbury, Connecticut, United States
Withdrawn
United States, Florida
Bradenton, Florida, United States
Withdrawn
United States, Florida
Brooksville, Florida, United States
Withdrawn
United States, Florida
Hialeah, Florida, United States
Recruiting
United States, Florida
Hialeah, Florida, United States
Completed
United States, Florida
Hialeah, Florida, United States
Withdrawn
United States, Florida
Miami, Florida, United States
Withdrawn
United States, Florida
Miami, Florida, United States
Recruiting
United States, Florida
New Port Richey, Florida, United States
Recruiting
United States, Florida
Opa Locka, Florida, United States
Recruiting
United States, Florida
Palm Harbor, Florida, United States
Withdrawn
United States, Florida
St. Petersburg, Florida, United States
Withdrawn
United States, Georgia
Perry, Georgia, United States
Recruiting
United States, Idaho
Eagle, Idaho, United States
Withdrawn
United States, Illinois
Springfield, Illinois, United States
Withdrawn
United States, Indiana
Evansville, Indiana, United States
Recruiting
United States, Louisiana
Baton Rouge, Louisiana, United States
Withdrawn
United States, Louisiana
Mandeville, Louisiana, United States
Recruiting
United States, Louisiana
Metairie, Louisiana, United States
Recruiting
United States, Louisiana
Sunset, Louisiana, United States
Recruiting
United States, Maine
Auburn, Maine, United States
Withdrawn
United States, Maine
Portland, Maine, United States
Withdrawn
United States, Maryland
Elkridge, Maryland, United States
Withdrawn
United States, Massachusetts
Brockton, Massachusetts, United States
Withdrawn
United States, Michigan
Bingham Farms, Michigan, United States
Withdrawn
United States, Michigan
Flint, Michigan, United States
Recruiting
United States, Michigan
Kalamazoo, Michigan, United States
Completed
United States, Michigan
Royal Oak, Michigan, United States
Recruiting
United States, Michigan
Troy, Michigan, United States
Recruiting
United States, Mississippi
Olive Branch, Mississippi, United States
Recruiting
United States, Mississippi
Picayune, Mississippi, United States
Recruiting
United States, New Mexico
Albuquerque, New Mexico, United States
Recruiting
United States, New Mexico
Albuquerque, New Mexico, United States
Withdrawn
United States, New York
West Seneca, New York, United States
Recruiting
United States, North Carolina
Hickory, North Carolina, United States
Recruiting
United States, North Carolina
Mooresville, North Carolina, United States
Recruiting
United States, Ohio
Cincinnati, Ohio, United States
Withdrawn
United States, Ohio
Cleveland, Ohio, United States
Withdrawn
United States, Ohio
Columbus, Ohio, United States
Withdrawn
United States, Ohio
Franklin, Ohio, United States
Recruiting
United States, Ohio
Mason, Ohio, United States
Recruiting
United States, Ohio
Perrysburg, Ohio, United States
Recruiting
United States, Ohio
Zanesville, Ohio, United States
Recruiting
United States, Oklahoma
Oklahoma City, Oklahoma, United States
Recruiting
United States, Oklahoma
Yukon, Oklahoma, United States
Recruiting
United States, Oregon
Tualatin, Oregon, United States
Recruiting
United States, Pennsylvania
Fleetwood, Pennsylvania, United States
Recruiting
United States, Pennsylvania
Jersey Shore, Pennsylvania, United States
Withdrawn
United States, Pennsylvania
Norristown, Pennsylvania, United States
Recruiting
United States, Pennsylvania
Pittsburgh, Pennsylvania, United States
Recruiting
United States, South Dakota
Rapid City, South Dakota, United States
Recruiting
United States, Tennessee
Nashville, Tennessee, United States
Recruiting
United States, Texas
Austin, Texas, United States
Recruiting
United States, Texas
Bellaire, Texas, United States
Recruiting
United States, Texas
Dallas, Texas, United States
Recruiting
United States, Texas
Houston, Texas, United States
Recruiting
United States, Texas
Houston, Texas, United States
Withdrawn
United States, Texas
Pearland, Texas, United States
Recruiting
United States, Texas
Plano, Texas, United States
Recruiting
United States, Utah
Bountiful, Utah, United States
Recruiting
United States, Utah
Salt Lake City, Utah, United States
Withdrawn
United States, Utah
Salt Lake City, Utah, United States
Recruiting
United States, Virginia
Danville, Virginia, United States
Recruiting
United States, Virginia
Norfolk, Virginia, United States
Recruiting
United States, Virginia
Richmond, Virginia, United States
Recruiting
United States, Virginia
Virginia Beach, Virginia, United States
Withdrawn
Argentina, MS
Olive Branch, MS, Argentina
Withdrawn
Argentina
Buenos Aires, Argentina
Recruiting
Argentina
Caba, Argentina
Recruiting
Argentina
Cordoba, Argentina
Recruiting
Argentina
Cordoba, Argentina
Withdrawn
Argentina
Mar Del Plata, Argentina
Recruiting
Argentina
Mendoza, Argentina
Withdrawn
Argentina
Moron, Argentina
Recruiting
Argentina
Rosario, Argentina
Recruiting
Argentina
Rosario, Argentina
Withdrawn
Argentina
Zarate, Argentina
Recruiting
Brazil
Belem, Brazil
Withdrawn
Brazil
Belo Horizonte, Brazil
Withdrawn
Brazil
Brasilia, Brazil
Withdrawn
Brazil
Campinas, Brazil
Withdrawn
Brazil
Curitiba, Brazil
Withdrawn
Brazil
Fortaleza, Brazil
Withdrawn
Brazil
Goiânia, Brazil
Withdrawn
Brazil
Marília, Brazil
Withdrawn
Brazil
Mogi Das Cruzes, Brazil
Withdrawn
Brazil
Passo Fundo, Brazil
Recruiting
Brazil
Recife, Brazil
Withdrawn
Brazil
Rio De Janeiro, Brazil
Withdrawn
Brazil
Sao Paulo, Brazil
Withdrawn
Brazil
Sao Paulo, Brazil
Recruiting
Brazil
São Paulo, Brazil
Recruiting
Brazil
São Paulo, Brazil
Withdrawn
Czech Republic
Holesov, Czech Republic
Withdrawn
Czech Republic
Kromeriz, Czech Republic
Recruiting
Czech Republic
Pardubce, Czech Republic
Withdrawn
Czech Republic
Pardubice, Czech Republic
Recruiting
Czech Republic
Praha, Czech Republic
Recruiting
Czech Republic
Praha 8, Czech Republic
Recruiting
Czech Republic
Unicov, Czech Republic
Recruiting
Hungary
Balatonfured, Hungary
Recruiting
Hungary
Budapest, Hungary
Recruiting
Hungary
Eger, Hungary
Recruiting
Hungary
Gyõr, Hungary
Recruiting
Hungary
Szentes, Hungary
Withdrawn
Hungary
Szikszó, Hungary
Recruiting
Hungary
Zalaegerszeg, Hungary
Recruiting
Korea, Republic of
Goyang-Si, Korea, Republic of
Recruiting
Korea, Republic of
Seoul, Korea, Republic of
Recruiting
Korea, Republic of
Suwon, Korea, Republic of
Recruiting
Mexico
Aguascalientes, Mexico
Completed
Mexico
Celaya, Mexico
Recruiting
Mexico
Culiacan, Mexico
Withdrawn
Mexico
Durango, Mexico
Recruiting
Mexico
Guadalajara, Mexico
Recruiting
Mexico
Mexico, Mexico
Recruiting
Mexico
Monterrey, Mexico
Withdrawn
Mexico
Monterrey, Mexico
Recruiting
Mexico
Monterrey, Mexico
Not yet recruiting
Mexico
Pachuca De Soto, Mexico
Recruiting
Mexico
Queretaro, Mexico
Withdrawn
Mexico
Tampico, Mexico
Recruiting
Puerto Rico
Carolina, Puerto Rico
Recruiting
Puerto Rico
Ponce, Puerto Rico
Recruiting
Puerto Rico
Ponce, Puerto Rico
Withdrawn
Puerto Rico
San Juan, Puerto Rico
Withdrawn
Puerto Rico
San Juan, Puerto Rico
Recruiting
Puerto Rico
Trujillo Alto, Puerto Rico
Recruiting
Romania
Bacau, Romania
Recruiting
Romania
Brasov, Romania
Recruiting
Romania
Bucharest, Romania
Recruiting
Romania
Bucuresti, Romania
Recruiting
Romania
Oradea, Romania
Recruiting
Romania
Tg Mures, Romania
Recruiting
Russian Federation
Arkhangelsk, Russian Federation
Recruiting
Russian Federation
Arkhangelsk, Russian Federation
Withdrawn
Russian Federation
Barnaul, Russian Federation
Recruiting
Russian Federation
Barnaul, Russian Federation
Withdrawn
Russian Federation
Chelyabinsk, Russian Federation
Recruiting
Russian Federation
Kemerovo, Russian Federation
Recruiting
Russian Federation
Kursk, Russian Federation
Withdrawn
Russian Federation
Moscow, Russian Federation
Withdrawn
Russian Federation
Moscow, Russian Federation
Recruiting
Russian Federation
Novosibirsk, Russian Federation
Withdrawn
Russian Federation
Omsk, Russian Federation
Withdrawn
Russian Federation
Penza, Russian Federation
Recruiting
Russian Federation
Perm, Russian Federation
Withdrawn
Russian Federation
Rostov-On-Don, Russian Federation
Recruiting
Russian Federation
Saint Petersburg, Russian Federation
Withdrawn
Russian Federation
Saint Petersburg, Russian Federation
Recruiting
Russian Federation
Saint-Petersburg, Russian Federation
Recruiting
Russian Federation
Samara, Russian Federation
Recruiting
Russian Federation
Saratov, Russian Federation
Recruiting
Russian Federation
Smolensk, Russian Federation
Recruiting
Russian Federation
St Petersburg, Russian Federation
Not yet recruiting
Russian Federation
St Petersburg, Russian Federation
Recruiting
Russian Federation
St-Petersburg, Russian Federation
Recruiting
Russian Federation
Syktyvkar, Russian Federation
Recruiting
Russian Federation
Tomsk, Russian Federation
Recruiting
Russian Federation
Tyumen, Russian Federation
Recruiting
Russian Federation
Voronezh, Russian Federation
Recruiting
Slovakia
Banska Bystrica, Slovakia
Recruiting
Slovakia
Bratislava, Slovakia
Recruiting
Slovakia
Malacky, Slovakia
Recruiting
Slovakia
Presov, Slovakia
Recruiting
Slovakia
Rimavska Sobota, Slovakia
Recruiting
Slovakia
Sahy, Slovakia
Recruiting
Slovakia
Trebisov, Slovakia
Recruiting
South Africa
Cape Town, South Africa
Recruiting
South Africa
Durban, South Africa
Recruiting
South Africa
Durban, South Africa
Completed
South Africa
Halfway, South Africa
Recruiting
South Africa
Johannesburg, South Africa
Recruiting
South Africa
Johannesburg N/A, South Africa
Recruiting
South Africa
Paarl, South Africa
Withdrawn
South Africa
Soweto, Johannesburg, South Africa
Recruiting
South Africa
Worcester, South Africa
Withdrawn
South Africa
Worcester, South Africa
Recruiting
Turkey
Ankara, Turkey
Not yet recruiting
Turkey
Antalya, Turkey
Not yet recruiting
Turkey
Canakkale, Turkey
Not yet recruiting
Turkey
Denizli, Turkey
Not yet recruiting
Turkey
Gaziantep, Turkey
Not yet recruiting
Turkey
Isparta, Turkey
Not yet recruiting
Turkey
Kahramanmaras, Turkey
Not yet recruiting
Turkey
Kayseri, Turkey
Not yet recruiting
Turkey
Malatya, Turkey
Not yet recruiting
Turkey
Samsun, Turkey
Not yet recruiting
Ukraine
Cherkasy, Ukraine
Recruiting
Ukraine
Dnepropetrovsk, Ukraine
Recruiting
Ukraine
Donetsk, Ukraine
Recruiting
Ukraine
Ivano Frankivsk, Ukraine
Recruiting
Ukraine
Kharkov, Ukraine
Recruiting
Ukraine
Kiev, Ukraine
Recruiting
Ukraine
Kyiv, Ukraine
Recruiting
Ukraine
Lviv, Ukraine
Recruiting
Ukraine
Odesa, Ukraine
Recruiting
Ukraine
Poltava, Ukraine
Recruiting
Ukraine
Simferopol, Ukraine
Not yet recruiting
Ukraine
Sumy, Ukraine
Recruiting
Ukraine
Vinnitsa, Ukraine
Withdrawn
Ukraine
Zaporozhye, Ukraine
Recruiting